Founded in March 2016, Extruded Pharmaceuticals Ltd (EPL) employs an interdisciplinary team of pharmaceutical specialists based in Birmingham. We serve a wide array of international clients, aiming to improve the clinical performance of active pharmaceutical ingredients (APIs) via local drug delivery and personalised medicines.
In collaboration with the University of Birmingham, EPL developed a platform implantable drug delivery technology that improves the clinical performance of APIs used in cancer treatment by delivering them directly to their required site of action. This approach allows for a lower dose to be administered, removing the issue of toxic side-effects commonly associated with cancer treatment thus improving patients’ quality of life.
These implants offer considerable benefit to global healthcare, through the improvement of the therapeutic efficacy of already approved drugs, thus negating the need for costly and time-consuming drug discovery programmes.
Our company works on a variety of pharmaceutical manufacturing projects.